Article

Segment 1 - Diagnosis and Prognosis of Multiple Myeloma

Moderator Michael Chernew, PhD, co-editor-in-chief, The American Journal of Managed Care, and professor, Leonard D. Schaeffer School of Healthcare Policy, Harvard, leads a panel discussion on multiple myeloma.

Moderator Michael Chernew, PhD, co-editor-in-chief, The American Journal of Managed Care, and professor, Leonard D. Schaeffer School of Healthcare Policy, Harvard, leads a panel discussion on multiple myeloma. He is joined by panel experts Jack Goldberg, MD, clinical professor of medicine and chief, Division of Hematology and Medical Oncology, Penn Presbyterian Medical Center; Shaji K. Kumar, MD, professor of medicine and consultant, Division of Hematology and Blood and Marrow Transplantation, Mayo Clinic; Gene Reeder, Rph, PhD, director, Managed Care Networks, Xcenda; and Anne Quinn Young, MPH, vice president of development and strategic partnerships, Multiple Myeloma Research Foundation (MMRF).

The panelists begin with a general discussion that focuses on the diagnosis and prognosis of multiple myeloma, including if early diagnosis is possible. Dr Kumar begins by analyzing whether there is evidence for familial myeloma.

Related Videos
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
dr joseph alvarnas
dr joseph alvarnas
Neal D. Shore, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo